Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386758835> ?p ?o ?g. }
Showing items 1 to 94 of
94
with 100 items per page.
- W4386758835 endingPage "e19818" @default.
- W4386758835 startingPage "e19818" @default.
- W4386758835 abstract "Neoadjuvant immunotherapy, the focus of current research and treatment modality for long-term survival, has become one of the main options in supporting primary treatment interventions in early NSCLC.This was a retrospective analysis of patients with locally resectable NSCLC who received the neoadjuvant drug pembrolizumab combined with chemotherapy and underwent surgical resection. Pathological responses, PFS and OS in the whole sample and subgroups were analyzed.Of the 61 patients included in this retrospective analysis, 31 (50.82%) achieved a pCR, and 38 (62.30%) obtained an MPR. Patients with a pCR had significantly higher OS than the non-pCR group (HR = 0.093, P = 0.0227); patients with an MPR also had significantly elevated OS compared with the non-MPR group (HR = 0.05357, P = 0.0169). Patients with lymph node metastasis after surgery had significantly reduced OS (HR = 0.01607, p = 0.0004) and PFS (HR = 0.08757, p = 0.0004) than those without lymph node metastasis. There was no significant difference in OS and PFS between squamous cell carcinomas (SCC) group and adenocarcinomas (AD) group. No significant differences in OS and PFS were found between patients administered 2 and 3 cycles of neoadjuvant therapy before surgery, between those administered ≤5 and > 5 cycles of adjuvant therapy post-surgery, and between patients with TPS <50% and ≥50% (all P > 0.05).Neoadjuvant immunochemotherapy with pembrolizumab plus chemotherapy in non-small cell lung cancer is safe and tolerable. Both pCR and MPR were closely associated with OS and PFS, reflecting a good response of tumor tissues to drug therapy. Lymph node metastasis after surgery was a poor prognostic factor, reducing OS and PFS." @default.
- W4386758835 created "2023-09-16" @default.
- W4386758835 creator A5008335787 @default.
- W4386758835 creator A5016786663 @default.
- W4386758835 creator A5042501380 @default.
- W4386758835 creator A5057477569 @default.
- W4386758835 creator A5076930880 @default.
- W4386758835 date "2023-09-01" @default.
- W4386758835 modified "2023-10-11" @default.
- W4386758835 title "Neoadjuvant immunochemotherapy with pembrolizumab plus chemotherapy in resectable non-small cell lung cancer" @default.
- W4386758835 cites W2798160602 @default.
- W4386758835 cites W2889646458 @default.
- W4386758835 cites W2914335731 @default.
- W4386758835 cites W3005124847 @default.
- W4386758835 cites W3082669180 @default.
- W4386758835 cites W3089755582 @default.
- W4386758835 cites W3103134014 @default.
- W4386758835 cites W3128410443 @default.
- W4386758835 cites W3128646645 @default.
- W4386758835 cites W3167135167 @default.
- W4386758835 cites W3186781833 @default.
- W4386758835 cites W3189520376 @default.
- W4386758835 cites W3195667012 @default.
- W4386758835 cites W3206312085 @default.
- W4386758835 cites W4206160381 @default.
- W4386758835 cites W4220843595 @default.
- W4386758835 cites W4221102549 @default.
- W4386758835 cites W4226382697 @default.
- W4386758835 cites W4281808064 @default.
- W4386758835 cites W4281856400 @default.
- W4386758835 cites W4294586494 @default.
- W4386758835 cites W4315701757 @default.
- W4386758835 cites W70383152 @default.
- W4386758835 doi "https://doi.org/10.1016/j.heliyon.2023.e19818" @default.
- W4386758835 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37809935" @default.
- W4386758835 hasPublicationYear "2023" @default.
- W4386758835 type Work @default.
- W4386758835 citedByCount "0" @default.
- W4386758835 crossrefType "journal-article" @default.
- W4386758835 hasAuthorship W4386758835A5008335787 @default.
- W4386758835 hasAuthorship W4386758835A5016786663 @default.
- W4386758835 hasAuthorship W4386758835A5042501380 @default.
- W4386758835 hasAuthorship W4386758835A5057477569 @default.
- W4386758835 hasAuthorship W4386758835A5076930880 @default.
- W4386758835 hasBestOaLocation W43867588351 @default.
- W4386758835 hasConcept C121608353 @default.
- W4386758835 hasConcept C126322002 @default.
- W4386758835 hasConcept C143998085 @default.
- W4386758835 hasConcept C167135981 @default.
- W4386758835 hasConcept C2776256026 @default.
- W4386758835 hasConcept C2776694085 @default.
- W4386758835 hasConcept C2777701055 @default.
- W4386758835 hasConcept C2777863537 @default.
- W4386758835 hasConcept C2778292576 @default.
- W4386758835 hasConcept C2779013556 @default.
- W4386758835 hasConcept C2780057760 @default.
- W4386758835 hasConcept C2780849966 @default.
- W4386758835 hasConcept C530470458 @default.
- W4386758835 hasConcept C71924100 @default.
- W4386758835 hasConceptScore W4386758835C121608353 @default.
- W4386758835 hasConceptScore W4386758835C126322002 @default.
- W4386758835 hasConceptScore W4386758835C143998085 @default.
- W4386758835 hasConceptScore W4386758835C167135981 @default.
- W4386758835 hasConceptScore W4386758835C2776256026 @default.
- W4386758835 hasConceptScore W4386758835C2776694085 @default.
- W4386758835 hasConceptScore W4386758835C2777701055 @default.
- W4386758835 hasConceptScore W4386758835C2777863537 @default.
- W4386758835 hasConceptScore W4386758835C2778292576 @default.
- W4386758835 hasConceptScore W4386758835C2779013556 @default.
- W4386758835 hasConceptScore W4386758835C2780057760 @default.
- W4386758835 hasConceptScore W4386758835C2780849966 @default.
- W4386758835 hasConceptScore W4386758835C530470458 @default.
- W4386758835 hasConceptScore W4386758835C71924100 @default.
- W4386758835 hasIssue "9" @default.
- W4386758835 hasLocation W43867588351 @default.
- W4386758835 hasLocation W43867588352 @default.
- W4386758835 hasOpenAccess W4386758835 @default.
- W4386758835 hasPrimaryLocation W43867588351 @default.
- W4386758835 hasRelatedWork W2062691140 @default.
- W4386758835 hasRelatedWork W2517747645 @default.
- W4386758835 hasRelatedWork W2521234799 @default.
- W4386758835 hasRelatedWork W2585407512 @default.
- W4386758835 hasRelatedWork W2891524425 @default.
- W4386758835 hasRelatedWork W2945780494 @default.
- W4386758835 hasRelatedWork W3037068108 @default.
- W4386758835 hasRelatedWork W3041652591 @default.
- W4386758835 hasRelatedWork W4200023723 @default.
- W4386758835 hasRelatedWork W4281564228 @default.
- W4386758835 hasVolume "9" @default.
- W4386758835 isParatext "false" @default.
- W4386758835 isRetracted "false" @default.
- W4386758835 workType "article" @default.